CAS: 5051-62-7; 2-(2,6-Dichlorobenzylidene)Hydrazine-1-Carboximidamide

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号83-38-5 2,6-二氯苯甲醛 | CAS号79-17-4 氨基胍盐酸盐

合成工艺路线路线简述

    📜胍诺沙苄置于cytochrome B5,Mitochondrial Amidoxime Reducing Component 1,Nadh Cytochrome B5 Reductase,还原型辅酶ⅰ体系中,化学反应生成 胍那苄
    参考文献:The Fourth Molybdenum Containing Enzyme Marc: Cloning And Involvement In The Activation Of N-Hydroxylated Prodrugs
    标题:The Fourth Molybdenum Containing Enzyme Marc: Cloning And Involvement In The Activation Of N-Hydroxylated Prodrugs
    摘要:The Recently Discovered Mammalian Molybdoprotein Marc1 Is Capable Of Reducing N-Hydroxylated Compounds. Upon Reconstitution With Cytochrome B(5) And B5 Reductase,Benzamidoxime,Pentamidine,And Diminazene Amidoximes,N-Hydroxymelagatran,Guanoxabenz,And N-Hydroxydebrisoquine Are Efficiently Reduced. These Substances Are Amidoxime/n-Hydroxyguanidine Prodrugs,Leading To Improved Bioavailability Compared To The Active Amidines/guanidines. Thus,The Recombinant Enzyme Allows Prediction About In Vivo Reduction Of N-Hydroxylated Prodrugs. Furthermore,The Prodrug Principle Is Not Dependent On Cytochrome P450 Enzymes.
    DOI:10.1021/jm8010417

    海关参考信息

    专利信息


    专利号:US-2008090885-A1
    优先权日:2006-10-12
    标题:Preparation of losartan 5-carboxylic acid and use thereof
    发明人:CHEN LIQIN; LI JIAN; SHEN YINGZHONG
    权利人:CHEN LIQIN; LI JIAN; SHEN YINGZHONG
    摘要:A method for synthesis of losartan 5-carboxylic acid (EXP-3174).

    专利号:US-RE41998-E
    优先权日:1990-02-26
    标题 :Compositions and methods of treatment of sympathetically maintained pain
    发明人:CAMPBELL JAMES N
    权利人:ARCLON THERAPEUTICS INC
    摘要:Sympathetically maintained pain is treated topically by administering to the site where sympathetically maintained pain is present an α-1-adrenergic antagonist, α-2-adrenergic agonist, or other drug that depletes or blocks synthesis of sympathetic norepinephrine, known collectively as sympatholytic agents. Chemical formulas for several sympatholytic agents are given.

    专利号:US-4656291-A
    优先权日:1985-03-15
    标 题 :Process for producing amidine sulfonic acids
    发明人:MARYANOFF CYNTHIA A; PLAMPIN JAMES N; STANZIONE ROBIN C
    权利人:MCNEILAB INC
    摘要:An efficient synthesis of quanidines, e.g. of the formula (III), by oxidizing a thiourea, e.g. of the following formula (II): with H2O2 and a molybdenum catalyst to yield an aminoiminomethane sulfonic acid which can then be reacted with an amine followed by optional transamination steps.

    专利号:US-4781866-A
    优先权日:1985-03-15
    标题 :Process for producing amidine sulfonic acid intermediates for guanidines
    发明人:MARYANOFF CYNTHIA A; PLAMPIN JAMES N; STANZIONE ROBIN C
    权利人:MCNEILAB INC
    摘要:An efficient synthesis of quanidines, e.g. of the formula (III), by oxidizing a thiourea, e.g. of the following formula (II): with H2O2 and a molybdenum catalyst to yield an aminoiminomethane sulfonic acid which can then be reacted with an amine followed by optional transamination steps.

    专利号:US-2008107598-A1
    优先权日:2006-10-05
    标 题:Efficient Synthesis of Chelators for Nuclear Imaging and Radiotherapy: Compositions and Applications

    专利号:US-4851094-A
    优先权日:1985-03-15
    标 题:Process for producing amidine sulfonic acid intermediates for guanidines
    发明人:MARYANOFF CYNTHIA A; PLAMPIN JAMES N; STANZIONE ROBIN C
    权利人:MCNEILAB INC
    摘要:An efficient synthesis of quanidines, e.g. of the formula (III), by oxidizing a thiourea, e.g. of the following formula (II): (III) (II) with H2O2 and a molybdenum catalyst to yield an aminoiminomethane sulfonic acid which can then be reacted with an amine followed by optional transamination steps.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Martínez G, Duran-Aniotz C, Cabral-Miranda F, Vivar JP, Hetz C. Endoplasmic reticulum proteostasis impairment in aging. Aging Cell. 2017 Aug;16(4):615-623. doi: 10.1111/acel.12599. Epub 2017 Apr 23. Review.
    2: Montazeri M, Sharif M, Sarvi S, Mehrzadi S, Ahmadpour E, Daryani A. A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016). Front Microbiol. 2017 Jan 20;8:25. doi: 10.3389/fmicb.2017.00025. eCollection 2017. Review.
    3: Clayton BLL, Popko B. Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia. Brain Res. 2016 Oct 1;1648(Pt B):594-602. doi: 10.1016/j.brainres.2016.03.046. Epub 2016 Apr 4. Review.

    合成参考文献


    摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
    摘要:Takishita S, Yamazato M. [Centrally-acting antihypertensive drugs]. Nihon Rinsho. 2004 Mar;62 Suppl 3():591–5.
    参考文献:10.1016/j.peptides.2008.02.011
    摘要:Yuan K, Rhee KS, Park WH, Kim SW, Kim SH. Different response of ANP secretion to adrenoceptor stimulation in renal hypertensive rat atria. Peptides. 2008 Jul;29(7):1207–15. doi: 10.1016/j.peptides.2008.02.011.
    参考文献:10.1007/s00213-005-0220-3
    摘要:Massé F, Hascoët M, Dailly E, Bourin M. Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test. Psychopharmacology (Berl). 2006 Jan;183(4):471–81. doi: 10.1007/s00213-005-0220-3.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知